Benzinga·2025-12-18 13:04Summary of Key Points Core Viewpoint - U.S. stock futures are showing positive movement, with Dow futures increasing by approximately 100 points. However, Birkenstock Holding PLC's shares experienced a significant decline in pre-market trading despite reporting better-than-expected earnings and sales figures. Company Performance - Birkenstock reported fourth-quarter earnings of $0.60 per share, surpassing the analyst consensus estimate of $0.40 per share. The company's quarterly sales reached $615.404 million, exceeding the consensus estimate of $606.670 million [1]. - For FY2026, Birkenstock anticipates adjusted EPS in the range of $2.22 to $2.40, slightly below the market estimate of $2.30. The projected sales for the same period are between $2.689 billion and $2.747 billion, compared to expectations of $2.750 billion [2]. Market Reactions - Following the earnings report, Birkenstock shares fell by 10.6% to $41.50 in pre-market trading [2]. - Other companies also experienced declines in pre-market trading, including Insmed Inc, which dropped 20.1% after halting its Brensocatib CRSsNP program, and DBV Technologies SA, which fell 12.6% despite a previous surge [3].